Targeted therapy for cutaneous malignancies

Aleksandar Sekulic, Michael R. Migden, Anthony E. Oro, Luc Dirix, Karl D. Lewis, John D. Hainsworth, James A. Solomon, Simon Yoo, Sarah T. Arron, Philip A. Friedlander, Ellen Marmur, Charles M. Rudin, Anne Lynn S. Chang, Jennifer A. Low, Howard M. Mackey, Robert L. Yauch, Richard A. Graham, Josina C. Reddy, Axel Hauschild, Eve MaubecPeter Petrow, Isabelle Scheer-Senyarich, Pierre Duvillard, Ludovic Lacroix, Julien Gelly, Agnès Certain, Xavier Duval, Béatrice Crickx, Valérie Buffard, Nicole Basset-Seguin, Pierre Saez, Anne Duval-Modeste, Adamski Bénédicte, Mansard Henri, Grange Sandrine, Dompmartin Florent, Faivre Anne, Mentré Sandrine, Avril France, Marie Françoise, G. V. Long, A. Hauschild, M. Santinami, V. Atkinson, M. Mandal, V. Chiarion-Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, C. Robert, L. Mortier, J. Schachter, D. Schadendorf, T. Lesimple, R. Plummer, R. Ji, P. Zhang, B. Mookerjee, J. Legos, R. Kefford, R. Dummer, J. M. Kirkwood

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    Abstract

    Targeted therapy holds great promise in advanced or metastatic cutaneous malignancies, although drugs can be expensive and have significant side effects. The following papers provide evidence for and describe outcomes and adverse effects of targeted therapy for these malignancies.

    Original languageEnglish
    Title of host publicationFoundational Papers in Oculoplastics
    PublisherSpringer International Publishing
    Pages389-400
    Number of pages12
    ISBN (Electronic)9783030927943
    ISBN (Print)9783030927936
    DOIs
    Publication statusPublished - 31 Jan 2022

    Keywords

    • Cutaneous malignancies
    • Eyelid cancer
    • Eyelid neoplasm
    • Skin cancer

    Cite this